Participants are motivated to take control of their health with convenient at-home lab testing, easy-to-follow instructions, and tailored next steps.
From distribution to evaluating results, the Everlywell platform handles it all. Our best-in-class customer support team is ready to help you and your participants.
We partner with CLIA-certified and CAP-accredited labs. Samples collected using our home collection kit may be processed by labs running Thermo Fisher Scientific technology.
As the leading consumer-initiated at-home
healthcare platform, we approach healthcare differently. We empower organizations to do the same.
Keeping your business open and safe during COVID-19
With a trusted testing solution.
Our platform handles the details, so you don’t have to
No need to guess where your participants are in the testing process. Everlywell Lens allows you to see the progress of each participant test. Participants are notified via text about the status of their test kit.
Options to ship COVID-19 Test Home Collection Kits to each participant’s home address or all to one location for distribution. Participants simply register their test kit on the Everlywell digital platform.
Sort and view all participant results in Everlywell Lens. Notifications alert you of positive COVID-19 test results that need immediate attention.
Everlywell COVID-19 Test Home Collection Kit
With Thermo Fisher Scientific Technology
COVID-19 testing is a valuable component of workplace safety protocols. The partnership between Everlywell and Thermo Fisher Scientific is one you can trust. Together, we’ll help your organization improve:
Sign up to learn about implementing Everlywell with Thermo Fisher Scientific Technology at your organization.
Neither the TaqPath COVID-19 Combo Kit, nor the Everlywell COVID-19 Test Home Collection Kit have been FDA cleared or approved, but both are authorized by FDA for Emergency Use Authorization (EUA) only.
The Everlywell kit is authorized only for the home collection and maintenance of nasal swab specimens to aid in detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens.
EUA amendment for use of TaqPath COVID-19 Combo Kit with Everlywell COVID-19 Test Home Collection Kit under development (“Proposed Amended EUA”). Proposed Amended EUA is not cleared for use nor commercially available.
Any EUA product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
A digital health platform
FDA authorized COVID-19 Test Home Collection Kit with comprehensive instructions